The results of mediating mechanism test. by Le Zhu (1771669)

Means scores of CAM and CAM-MYCS. by Senay Yildirim-Kahriman (22693464)

“…A moderate negative correlation was observed between CAM and CAM-MYCS scores (r = −0.511; p < 0.001), indicating that increased awareness of real causes is associated with decreased belief in myths. Regression analysis revealed that CAM scores were significantly predicted by academic year, being in the normal Body Mass Index (BMI) spectrum, and by having attended an oncology course (R² = 0.142; p < 0.001), whereas CAM-MYCS scores were predicted by academic year and high BMI values (R² = 0.072; p < 0.001). …”

ox-LDL stimulates cytotoxicity and pyroptosis among RAW264.7. by Ping-yu Cai (12389929)

Subjects:

Metabolic and molecular effects of high-fat diet (HFD). by Ping-yu Cai (12389929)

Subjects:

miR-150-5p inhibition modulates pyroptosis and FoxO3a/ARC signaling in ApoE^-/- mice. by Ping-yu Cai (12389929)

Subjects:

Therapeutic effects of miR-150-5p inhibition on ox-LDL-induced pyroptosis in RAW264.7 macrophages. by Ping-yu Cai (12389929)

Subjects:

Therapeutic effects of miR-150-5p inhibition on atherosclerotic lesion development. by Ping-yu Cai (12389929)

Subjects:

Dysregulation of miR-150-5p and its target FoxO3a in atherosclerosis (AS). by Ping-yu Cai (12389929)

Subjects:

The cleft width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

Subjects:

The dental arch length at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

Subjects:

The alveolar width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

Subjects:

The dental arch width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

Subjects:

IFA did not affect LPS-induced inflammation response. by Tingting Wang (123983)

Subjects:

IFA treatment facilitated host immune clearance of hypervirulent <i>K</i>. <i>pneumoniae</i> by targeting capsule. by Tingting Wang (123983)

Subjects:

IFA effectively limited bacterial dissemination and protected mice from lethal hypervirulent <i>K</i>. <i>pneumoniae</i> pneumonia. by Tingting Wang (123983)

Subjects:

IFA reduced the virulence of hypervirulent <i>K</i>. <i>pneumoniae</i> in <i>G</i>. <i>mellonella</i> larvae. by Tingting Wang (123983)

Subjects:

IFA reduced the capsular biosynthesis through altering bacterial metabolism. by Tingting Wang (123983)

Subjects:

IFA effectively reduced the production of <i>K</i>. <i>pneumoniae</i> capsule. by Tingting Wang (123983)

Subjects:

IFA abrogated capsule-associated hypermucoviscosity phenotypes of hypervirulent <i>K</i>. <i>pneumoniae</i>. by Tingting Wang (123983)

Subjects:

Validation of distinct contribution of capsule and hypercapsule-associated HMV in IFA-conferred protection against hvKP infection using a <i>ΔrmpD</i>-K7 mutant. by Tingting Wang (123983)

Subjects: